Allentown pharmaceutical company plans $15 million expansion, will add 100 jobs
U.S. Specialty Formulations, a leading pharmaceutical company in Allentown, is set to inject a significant economic boost into the Lehigh Valley with a planned $15 million expansion. This major development will enhance the company’s biopharma facility, introducing new clean room suites and state-of-the-art automated packaging and inspection equipment. The expansion, backed by $4.7 million in funding, will allow USSF to handle larger projects and is expected to create over 100 new jobs. According to CEO Kyle Flanigan, this growth marks a transformative step for the company, reinforcing its commitment to delivering risk-reducing pharmaceutical solutions. The project is slated for completion by the end of 2025, positioning USSF to better serve its global partners and clients. For more information, read the full article on LehighValleyNews.com
Kyle Flanigan, Co-founder of U.S. Specialty Formulations, speaks about the company in 2022 at its Allentown facility. The location is expected to grow by $15 millio